학술논문
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas.
Document Type
Article
Author
Dimou, Maria; Papageorgiou, Sotirios G.; Stavroyianni, Niki; Katodritou, Eirini; Tsirogianni, Maria; Kalpadakis, Christina; Banti, Anastasia; Arapaki, Maria; Iliakis, Theodoros; Bouzani, Maria; Verrou, Eugenia; Spanoudakis, Emmanouil; Giannouli, Stavroula; Marinakis, Theodoros; Mandala, Evdokia; Mparmparousi, Despoina; Sachanas, Sotirios; Dalekou‐Tsolakou, Maria; Hatzimichael, Eleftheria; Vadikolia, Chryssa
Source
Hematological Oncology; Aug2021, Vol. 39 Issue 3, p336-348, 13p
Subject
Language
ISSN
02780232
Abstract
Copyright of Hematological Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)